Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Newly published results from a clinical study of the Diabetes Insulin Guidance System (DIGS(TM)), under development by Hygieia, Inc., demonstrate DIGS' potential to improve blood glucose control for insulin-using patients with type 2 or type 1 diabetes. DIGS automatically adjusted insulin dosage based on each individual's reported blood glucose results. Over the 12-week intervention period of the study, investigators observed:
-- Out of a total of 1,734 individual dosage adjustments, the study team over-rode the DIGS-instructed dosage only twice.
-- Mean HbA1c levels decreased from a baseline of 8.4%(?0.8) to 7.9%(?0.9); (p<0.05);
-- Average patient blood glucose levels improved progressively from a baseline of 174.2 mg/dL(?36.7) to 163.3mg/dL(?35.1); (p<0.03); and
-- Glucose levels falling below the hypoglycemic threshold (glucose < 65 mg/dL) during the 12-week active phase were significantly milder than the ones reported during the 4-week run-in period (P = 0.02).
http://www.marketwatch.com/story/fi...in-clinical-study-says-hygieia-inc-2012-05-09
-- Out of a total of 1,734 individual dosage adjustments, the study team over-rode the DIGS-instructed dosage only twice.
-- Mean HbA1c levels decreased from a baseline of 8.4%(?0.8) to 7.9%(?0.9); (p<0.05);
-- Average patient blood glucose levels improved progressively from a baseline of 174.2 mg/dL(?36.7) to 163.3mg/dL(?35.1); (p<0.03); and
-- Glucose levels falling below the hypoglycemic threshold (glucose < 65 mg/dL) during the 12-week active phase were significantly milder than the ones reported during the 4-week run-in period (P = 0.02).
http://www.marketwatch.com/story/fi...in-clinical-study-says-hygieia-inc-2012-05-09